Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS), David and Lucile Packard Foundation, American Heart Association
Translation termination is an essential cellular process, which is also of therapeutic interest for diseases that manifest from premature stop codons. In eukaryotes, translation termination requires eRF1, which recognizes stop codons, catalyzes the release of nascent proteins from ribosomes and facilitates ribosome recycling. The small molecule SRI-41315 triggers eRF1 degradation and enhances translational readthrough of premature stop codons. However, the mechanism of action of SRI-41315 on eRF1 and translation is not known. Here we report cryo-EM structures showing that SRI-41315 acts as a metal-dependent molecular glue between the N domain of eRF1 responsible for stop codon recognition and the ribosomal subunit interface near the decoding center. Retention of eRF1 on ribosomes by SRI-41315 leads to ribosome collisions, eRF1 ubiquitylation and a higher frequency of translation termination at near-cognate stop codons. Our findings reveal a new mechanism of release factor inhibition and additional implications for pharmacologically targeting eRF1.
Organizational Affiliation:
Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
For questions/corrections to specific PDB entries, including citation updates: email deposit-help@mail.wwpdb.org
Thank you for providing your feedback! Someone will be in touch with you shortly. This window will automatically close in 5 seconds.
Apologies, our feedback server is currently unavailable and we are troubleshooting the issue. In the meantime, please copy and paste the below information into an email addressed to info@rcsb.org
Download Mendeley
